@Demetrix

Demetrix is a biotechnology company dedicated to researching and producing bioactive ingredients.

 Berkeley, CA
demetrix.com
Joined September 2017
  • Tweets195
  • Following46
  • Followers150
37Media
In our Rare Access this month, we chat with Victoria Kim, Associate Scientist in High Throughput Screening. We discuss her transition into biotech, picking winning strains, and much more. ow.ly/NVUw50KW8eV
Happy Friday! Here's one final reminder that Demetrix will be featured on @Insidebp on @FoxBusiness this Sunday, September 25th at 3:30pm EST. Learn more about the progress we are making in bringing rare cannabinoids to market! ow.ly/j5jE50KRLGP
3
Demetrix is thrilled to be exhibiting at Beauty Accelerate next week in New York City, September 28th-29th. Don't miss our Innovation Talk on day two at 2:35pm as we discuss "Elucidating the Benefits of CBG". ow.ly/3yjr50KPFSo
2
Next Sunday, September 25th at 3:30pm EST, Demetrix will appear on @Insidebp airing on @FoxBusiness Tune in to learn more about our first product, Arete-G™, our company and the work we are doing here in Berkeley.
1
2
There are many exciting rare bioactives that have entered the market and continue to drive innovation. Rare bioactive ingredients, including cannabinoids have the potential to better lives in a variety of applications. ow.ly/KpEP50KKUtZ
1
Did you know Demetrix recently doubled our lab space? We discuss this and much more with Torre Meeks, Facilities Coordinator at Demetrix. ow.ly/vGLN50Kxoca
2
Data from our recent research may indicate that CBG has potential to act against the strains of fungi that can cause scalp conditions like dandruff. Learn more about what we have discovered in our recent blog post. ow.ly/xFGN50Kflmj
1
Last week, the National Institutes of Health (NIH) and eight of its component agencies presented their plan to research the therapeutic potential of minor cannabinoids. The list included CBG, CBN, CBC, and several others. @MarijuanaMoment ow.ly/e2Kj50Ka45v
1
1
How can an early career in winemaking lead to a job at Demetrix? Learn more in our Rare Access interview featuring Jeremy Gruber, Process Engineer at Demetrix! ow.ly/hQLg50K6EHv
We know cannabinoids have benefits, but why research rare cannabinoids? With limited access previously, scientific research has been limited. Learn about the new studies providing insights on these promising bioactives! ow.ly/gql250K2lvH
1
Meet the Demetrix team at day two of Cosmoprof North America in Las Vegas! Find us at booth #59034.
3
Our Rare Access interview this month month features Melissa Netwal, Scientist in Strain Engineering. We explore library core capabilities, team collaboration at Demetrix, and much more. demetrix.com/rare-access-str…
2
Cleanical skin care speaks to consumers’ desire for sustainably sourced, proven natural ingredients. Read more about cleanical skin care and how Demetrix delivers bioactives with proven benefits. ow.ly/7lfi50JM0PC
Demetrix is officially a member of @TheBioMADE. With this membership, Demetrix joins biotechnology companies that support the Biomade mission to secure America's future through bioindustrial manufacturing innovation, education, andcollaboration. ow.ly/3zQG50JJVYt
2
3
.@Demetrix, a biotechnology company that believes in the power of science to make the world a better place, is a new BioMADE member: buff.ly/37Y8Fjs
1
7
Demetrix will be exhibiting at Cosmoprof North America in Las Vegas July 12-14th. We look forward to sharing our exciting research on rare bioactives. Meet us at booth #59034!
3
Demetrix believes in the wonder of science. We develop bioactive ingredients with the greatest promise for human health and wellbeing. Follow us to learn more about our research and product portfolio. #cannabinoids #bioactives
2
Results of the largest clinical study on cannabinoids for pain treatment has been released by @OBXtracts and @radiclescience. The study analyzed 1,629 U.S.-based participants over a four week period, examining “the synergistic impact of cannabinoids." ow.ly/HEuq50JAhWy

Results From One of the Largest Clinical Trials on Cannabinoids, Pain Treatment Published | High...

Study results of “The OBX Pain Study on CBD and Rare Cannabinoids” were recently published and showcase evidence of the effectiveness of cannabinoid treatment.

hightimes.com
1
At Demetrix, we identify rare bioactive compounds, and through rigorous research, determine which ones to produce. Our technology enables us to produce rare bioactive ingredients at scale, with a light environmental footprint.
2
#biotech firm @Demetrix uses #fermentation to produce rare #cannabinoids for a range of health, wellness and beauty products in #Berkeley. #DiscoveredinBerkeley @warehamproperty #WestBerkeley #CityofBerkeley #researchanddevelopment #STEM @UCBerkeley @biocom
3
5
Load more